This landmark case pitted cancer survivors and the American Civil Liberties Union against the diagnostic company, Myriad Genetics.
Sources:
-
- June 13, 2013. Clarence Thomas and Antonin Scalia. Association for Molecular Pathology v. Myriad Genetics, Inc. Legal Information Institute. U.S. Supreme Court.
https://www.law.cornell.edu/supremecourt/text/12-398.
University, Judgment. - July 9, 2013. Megan Krench. “New Supreme Court Decision Rules That CDNA Is Patentable What It Means for Research and Genetic Testing.” Scientific American.
https://blogs.scientificamerican.com/guest-blog/new-supreme-court-decision-rules-that-cdna-is-patentablewhat-it-means-for-research-and-genetic-testing/.
Magazine. - January 2014. Jeremy McKinney. “‘It’s a Trap’: CDNA Is Patent Eligible? But Is It Patentable?” Oklahoma Journal of Law and Technology 10 (1): 31.
https://digitalcommons.law.ou.edu/cgi/viewcontent.cgi?article=1011&context=okjolt.
University, Law. - October 25, 2021. Megan Molteni. “Eight Years after a Landmark Supreme Court Ruling on DNA Ownership, Its Ramifications Are Becoming Clearer.” STAT.
https://www.statnews.com/2021/10/25/jorge-contreras-genome-defense-supreme-court-ruling-dna-ownership/,
https://sp-foundation.org/news-resources/news-article-archive.html/article/2021/10/29/eight-years-after-a-landmark-supreme-court-ruling-on-dna-ownership-its-ramifications-are-becoming-clearer.
Research Journal, Magazine.
See also, on this site:
- Attorney updates us on evidence found in a military case
- Report: mRNA “vaccines” are converted to DNA in the liver